HESX1 and neoplasm: Together, these findings demonstrate that the activation of oncogenic β-catenin in Hesx1+ pituitary embryonic precursors leads to cell transformation and formation of somatic mutations-bearing tumours, which are mostly not derived from the Hesx1 cell lineage.